Esomeprazole Magnesium With or Without Aspirin in Preventing Esophageal Cancer in Patients With Barrett Esophagus
Status:
Completed
Trial end date:
2011-06-01
Target enrollment:
Participant gender:
Summary
This randomized phase II trial is studying the effect of esomeprazole magnesium and aspirin
on tissue PGE2 levels compared with esomeprazole and placebo. This type of chemoprevention
treatment investigates the use of certain drugs to assess whether they assist in the
prevention of cancer. The use of esomeprazole magnesium with or without aspirin may help
prevent esophageal cancer in patients with Barrett esophagus.